Patents/Assignees

Biontech RNA Pharmaceuticals GmbH

1 patent in portfolio

US12281138utility2025
5′-cap-trinucleotide- or Higher Oligonucleotide Compounds and Their Use in Stabilizing RNA, Expressing Proteins in Therapy
0 cites